News | June 30, 2014

Telemed Solutions, GlobalMedia Partner to Distribute TM-12 PC-based, Wireless Resting 12-lead ECG

 TM-12 ECG Telemed Solutions GlobalMedia Group LLC

June 30, 2014 — Telemed Solutions has reached an agreement with GlobalMedia Group LLC to become the exclusive global distributor for the TM-12, a PC-based wireless resting 12-lead ECG. GlobalMed also will act as the exclusive master distributor for order fulfillment to Telemed Solutions existing distributors, resellers and customers.

Telemed Solutions CEO Ken Burns expects this relationship to get the TM-12 in markets and countries much sooner than once realized. “GlobalMed has relationships and experience in the private sector in addition to Federal and State agencies both domestic and abroad that will get the TM-12 into areas that would have taken us much longer to do so. In turn, we will be able to put more focus on our ECG Management System and concentrate on our other products,” Burns said.

GlobalMed will combine its expertise in hardware/software integration, international sales and marketing, product distribution and customer service with Telemed Solutions’s technology and expertise in ECG and related software to achieve a combined sales and marketing effort and hardware/software integration platform that will significantly broaden the revenue potential for both companies.

With the agreement, GlobalMed will use their extensive relationships and experience in the healthcare agencies of the U.S. Federal and state governments. GlobalMed shall offer Telemed Solutions products as pre-engineered, made in the United States, easily integrated retrofit additions to GlobalMed’s existing examination station footprint in the U.S. Department of Veteran’s Affairs and to the other Federal and State agencies currently utilizing GlobalMed’s examination stations and software. GlobalMed will rebrand the CardioVu software to TotalECG.

For more information: www.telemedcorp.com 

Related Content

FDA Clears AliveCor's KardiaMobile 6L as First Six-Lead Personal ECG Device
Technology | ECG | May 13, 2019
AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L...
One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

Feature | ECG | May 03, 2019 | Sanket Solanki
Technology has made its way into the healthcare sector and brought a drastic transformation.
Videos | ECG | March 05, 2019
This is a quick demo of the Schiller Cardiovit FT-1 electrocardiograph (ECG) system displayed at the ...
EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor
News | ECG | January 08, 2019
January 8, 2019 — A Mayo Clinic study finds that applying...
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer. 

Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the effe
HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...
ECG Study of NBA Players Shows Need for Sport-Specific Normative Data and Guidelines
News | ECG | December 08, 2017
Cardiologists at NewYork-Presbyterian/Columbia University Irving Medical Center compared electrocardiographic findings...
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG | August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG | August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG | July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Overlay Init